Genscript USA incorporated:1171214 [18-008231]
Ended Awarded
- Contract number
- 75N95A18F00022
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,460
Award facts
- Contract value 100% obligated
- $7,460.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Neurological Disorders and Stroke awarded a $7,460.22 blanket purchase agreement (BPA) call to Genscript USA Inc. on May 14, 2018, with completion scheduled for June 30, 2018. This firm fixed price contract, which utilized no set-aside designation, was performed at Genscript's facility in Piscataway, New Jersey. As a specialized biotechnology vendor, Genscript provided advanced molecular biology services and scientific research materials supporting the institute's neurological research initiatives.
Genscript USA Inc., headquartered in Piscataway, New Jersey, is an established federal contractor with demonstrated expertise in gene synthesis, protein production, antibody development, and custom biological research materials. The company has maintained a robust relationship with multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and the Department of Agriculture. This BPA call represents one of numerous awards the company has received for critical scientific support services, reflecting its capability to deliver specialized molecular biology solutions essential to federal biomedical research programs.
Quick answers
Who was awarded contract 75N95A18F00022?
75N95A18F00022 was awarded to Genscript USA Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on May 14, 2018.
How much is contract 75N95A18F00022 worth?
The government has obligated $7,460 on 75N95A18F00022.
Is contract 75N95A18F00022 an order under another contract?
Yes. 75N95A18F00022 is a BPA call under HHSN263201400039B, a blanket purchase agreement.
Was contract 75N95A18F00022 competed?
The extent of competition for 75N95A18F00022 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award